Combination Long-Acting β-Agonists and Inhaled Corticosteroids Compared With Long-Acting β-Agonists Alone in Older Adults With Chronic Obstructive Pulmonary DiseaseAndrea S. Gershon, Thérèse A. Stukel, Ruth Croxford et al.|JAMA|2014Cited by 122
Socioeconomic Status, Sex, Age and Access to Medications for COPD in Ontario, Canada.Andrea S. Gershon, Thérèse A. Stukel, Michael A. Campitelli et al.|PubMed|2015Cited by 9
Prescription Pathways from Initial Medication Use to Triple Therapy in Older COPD Patients: A Real-World Population StudyLili Jiang, Andrea S. Gershon, Shawn D. Aaron et al.|COPD Journal of Chronic Obstructive Pulmonary Disease|2022Cited by 5
Long-Acting β-Agonists With vs Without Inhaled Corticosteroids for COPD—ReplyAndrea S. Gershon, Matthew B. Stanbrook, Michael A. Campitelli|JAMA|2015Cited by 1
Bronchodilator Safety in Chronic Obstructive Pulmonary Disease—ReplyMatthew B. Stanbrook, Andrea S. Gershon, Michael A. Campitelli|JAMA Internal Medicine|2014Cited by 0